Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Plasma PK of a Single Oral Dose of Zoliflodacin in Healthy Male and Female Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, and plasma pharmacokinetics of a single oral dose of zoliflodacin in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gonorrhoea

Drugs mentioned

• Zoliflodacin (zoliflodacin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Gonorrhoea | Phase 1 | Status: COMPLETED | Results posted: 2019-03-18